GAPDH expression is increased in MYCN amplified tumours in all three datasets when compared to MYCN non‐amplified tumours (****p < 0.0001 Cangelosi, Kocak, ***p < 0.001 Asgharzadeh) (Figure 1C). Here, GAPDH is linked to neoplasm.